# Intravenous Versus Inhalational Anesthesia in Parkinson's Disease

> **NCT00615472** · NA · TERMINATED · sponsor: **Columbia University** · enrollment: 58 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Isoflurane
- **DRUG:** Remifentanil
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT00615472
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-10
- **Primary completion:** 2010-04
- **Final completion:** 2011-04
- **Target enrollment:** 58 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2015-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00615472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00615472, "Intravenous Versus Inhalational Anesthesia in Parkinson's Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00615472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*